NFKB1 and intervertebral disk degenerative disorder: In this study, we demonstrated that DHA ameliorated IDD via inhibiting PI3K/AKT and NF-κB signaling pathways and DHA might serve as a promising therapeutic drug for the treatment of IDD (Figure 8).